Codexis Appoints Claus Ladefoged to Global Enzyme Business Development Role GlobeNewswire - Mon Oct 1, 6:00AM CDT CMTX - Mon Oct 1, 6:00AM CDT
Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces the appointment of Claus Ladefoged as Director, Enzyme Business Development. Ladefoged has extensive experience in successfully...
Guest Host Tonight Jim Giaquinto - Zacks Investment Research - Thu Sep 27, 12:15AM CDT Jim Giaquinto - ZACKS - Thu Sep 27, 12:15AM CDT
Guest Host Tonight
The Zacks Analyst Blog Highlights: AeroVironment, BioSpecifics, Codexis, Avid and American Outdoor Zacks Equity Research - Zacks Investment Research - Tue Sep 11, 6:11AM CDT Zacks Equity Research - ZACKS - Tue Sep 11, 6:11AM CDT
The Zacks Analyst Blog Highlights: AeroVironment, BioSpecifics, Codexis, Avid and American Outdoor
5 Top-Ranked Nasdaq Stocks Defying the Worst September Start Sweta Killa - Zacks Investment Research - Mon Sep 10, 8:23AM CDT Sweta Killa - ZACKS - Mon Sep 10, 8:23AM CDT
There are still winners on the index across industries that are easily surviving the worst start to September and have a solid Zacks Rank #1 (Strong Buy) or 2 (Buy).
Report: Exploring Fundamental Drivers Behind Codexis, Kornit Digital, NewLink Genetics, NCS Multistage, Mountain Province Diamonds, and CSS Industries -- New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire - Mon Aug 20, 7:10AM CDT CMTX - Mon Aug 20, 7:10AM CDT
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Codexis, Inc. (NASDAQ:CDXS),...
E-commerce, Favorable Markets Drive Growth at Grainger (GWW) Zacks Equity Research - Zacks Investment Research - Wed Aug 15, 8:58AM CDT Zacks Equity Research - ZACKS - Wed Aug 15, 8:58AM CDT
W.W. Grainger (GWW) will gain from its investment in e-commerce and digital capabilities as well as executing supply chain management actions and efforts to strengthen relationships with customers.
Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates Zacks Equity Research - Zacks Investment Research - Wed Aug 8, 7:55PM CDT Zacks Equity Research - ZACKS - Wed Aug 8, 7:55PM CDT
Codexis (CDXS) delivered earnings and revenue surprises of 83.33% and 14.09%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Codexis: 2Q Earnings Snapshot APAI - Wed Aug 8, 6:48PM CDT APAI - Wed Aug 8, 6:48PM CDT
REDWOOD CITY, Calif. (AP) _ Codexis Inc. (CDXS) on Wednesday reported a loss of $3.7 million in its second quarter.
Codexis, Inc. to Host Earnings Call ACCESSWIRE - Wed Aug 8, 1:39PM CDT CMTX - Wed Aug 8, 1:39PM CDT
NEW YORK, NY / ACCESSWIRE / August 8, 2018 / Codexis, Inc. (NASDAQ: ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 8, 2018 at 4:30:00 PM Eastern Time.
Codexis to Hold Second Quarter 2018 Conference Call on August 8 GlobeNewswire - Wed Aug 1, 6:00AM CDT CMTX - Wed Aug 1, 6:00AM CDT
Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that it will report second quarter 2018 financial results after market close on Wednesday, August 8, 2018. Codexis management...
Codexis Appoints Dr. Hicham Alaoui, Veteran Drug Discoverer, as Vice President, Biotherapeutics Research & Development GlobeNewswire - Wed Jul 11, 6:00AM CDT CMTX - Wed Jul 11, 6:00AM CDT
Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces the appointment of Hicham Alaoui, Ph.D. to the newly created position of Vice President, Biotherapeutics Research & Development....
Free Technical Research on Clovis Oncology and Three More Biotech Equities ACCESSWIRE - Mon Jul 9, 9:46AM CDT CMTX - Mon Jul 9, 9:46AM CDT
Stock Research Monitor: CLSD, CDXS, and CHRS
Codexis Doses First Subjects in Phase 1a Trial of CDX-6114 GlobeNewswire - Mon Jul 9, 7:00AM CDT CMTX - Mon Jul 9, 7:00AM CDT
Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it has dosed the first subjects in a first-in-human Phase 1a dose-escalation trial with CDX-6114, its orally administered...
Cimpress Aims to Mitigate Risks by Decentralizing Operations Zacks Equity Research - Zacks Investment Research - Tue May 15, 10:09AM CDT Zacks Equity Research - ZACKS - Tue May 15, 10:09AM CDT
Cimpress' (CMPR) management has decentralized operations to improve accountability for customer satisfaction and capital returns, simplify decision-making and improve the speed of execution.
Here's Why You Should Add Sonoco (SON) to Your Portfolio Now Zacks Equity Research - Zacks Investment Research - Mon May 14, 8:17AM CDT Zacks Equity Research - ZACKS - Mon May 14, 8:17AM CDT
Sonoco's (SON) prospects remain bright on the back of solid earnings estimate revision activity as well as an upbeat guidance.
Codexis: 1Q Earnings Snapshot APAI - Thu May 10, 5:40PM CDT APAI - Thu May 10, 5:40PM CDT
REDWOOD CITY, Calif. (AP) _ Codexis Inc. (CDXS) on Thursday reported a loss of $4.7 million in its first quarter.
Codexis Reports First Quarter 2018 Financial Results GlobeNewswire - Thu May 10, 3:06PM CDT CMTX - Thu May 10, 3:06PM CDT
Total revenues increase 76% to $14.0 million on sharply higher R&D revenue
Porton Pharma Solutions and Codexis Launch Global Partnership BusinessWire - Mon Apr 23, 5:00AM CDT CMTX - Mon Apr 23, 5:00AM CDT
Codexis,
Inc. (NASDAQ: CDXS) and Porton
Pharma Solutions, Ltd. (SZSE: 300363) announce a strategic
collaboration to deploy Codexis' world-leading biocatalyst technology
within...
EnzymeWorks, Inc. Retracts Prior Press Release BusinessWire - Tue Apr 17, 6:48PM CDT CMTX - Tue Apr 17, 6:48PM CDT
EnzymeWorks has been ordered by the United States District Court for the
Northern District of California to retract its prior statements and
press releases pertaining in any way to the settlement...
New Research Coverage Highlights Alliance Resource Partners, MyoKardia, Pan American Silver, Stitch Fix, Codexis, and Chemical Financial -- Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire - Mon Apr 9, 7:10AM CDT CMTX - Mon Apr 9, 7:10AM CDT
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Alliance Resource Partners,...
